DAMON RASKIN: Open Payments
NPI 1528254133 · PACIFIC PALISADES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,377 in 186 payments from 31 companies in 2025. Trend: 2023 $72,849 · 2024 $21,554 · 2025 $20,377
Consulting: $7,903Speaker / faculty: $6,980Food & beverage: $4,220Travel & lodging: $1,205Education: $70
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $8,962 |
| Eli Lilly and Company | 3 | $7,533 |
| ABBVIE INC. | 42 | $802 |
| PFIZER INC. | 13 | $325 |
| AstraZeneca Pharmaceuticals LP | 13 | $295 |
| Indivior Inc. | 9 | $260 |
| Lundbeck LLC | 12 | $241 |
| Otsuka America Pharmaceutical, Inc. | 10 | $236 |
| HARMONY BIOSCIENCES LLC | 3 | $165 |
| Novo Nordisk Inc | 8 | $163 |
Products named: VIVITROL, REXULTI, VRAYLAR, SUBLOCADE, UBRELVY, NURTEC ODT, BREZTRI, QULIPTA.
Industry payments across CA — which companies pay providers there.
